<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 2012, the National Central <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Registry (NCCR) of China collected <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registration information for the year 2009 from <z:e sem="disease" ids="C0796563" disease_type="Neoplastic Process" abbrv="">local cancer</z:e> registries and analyzed it to describe the incidences and mortalities of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in China </plain></SENT>
<SENT sid="1" pm="."><plain>Based on the data quality criteria from NCCR, data from 104 registries covering 85,470,522 people (57,489,009 in urban areas and 27,981,513 in rural areas) were checked and evaluated </plain></SENT>
<SENT sid="2" pm="."><plain>The data from 72 registries were qualified and accepted for the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registry annual report in 2012 </plain></SENT>
<SENT sid="3" pm="."><plain>The total <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incident cases and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:hpo ids='HP_0011420'>deaths</z:hpo> were 244,366 and 154,310, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>The morphologically verified cases accounted for 67.23%, and 3.14% of the incident cases only had information from <z:hpo ids='HP_0011420'>death</z:hpo> certifications </plain></SENT>
<SENT sid="5" pm="."><plain>The crude incidence in the Chinese <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registration areas was 285.91/100,000 (317.97/100,000 in males and 253.09/100,000 in females) </plain></SENT>
<SENT sid="6" pm="."><plain>The age-standardized rates for incidences based on the Chinese standard population (ASRIC) and the world standard population (ASRIW) were 146.87/100,000 and 191.72/100,000, respectively, with a cumulative incidence of 22.08% </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality in the Chinese <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registration areas was 180.54/100,000 (224.20/100,000 in males and 135.85/100,000 in females) </plain></SENT>
<SENT sid="8" pm="."><plain>The age-standardized rates for mortalities based on the Chinese standard population(ASRMC) and the world standard population (ASRMW) were 85.06/100,000 and 115.65/100,000, respectively, and the cumulative mortality was 12.94% </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">Lung cancer</z:e>, <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:hpo ids='HP_0002896'>liver cancer</z:hpo>, <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo>, encephaloma, <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, female <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, and <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> were the most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, accounting for 75% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">Lung cancer</z:e>, <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>, <z:hpo ids='HP_0002896'>liver cancer</z:hpo>, <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo>, <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, encephaloma, <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> accounted for 80% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:hpo ids='HP_0011420'>deaths</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registration's population coverage has been increasing, and its data quality is improving </plain></SENT>
<SENT sid="12" pm="."><plain>As the basis of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> control program, the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registry plays an important role in directing anticancer strategies in the medium and long term </plain></SENT>
<SENT sid="13" pm="."><plain>Because <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> burdens are different in urban and rural areas in China, prevention and control efforts should be based on practical situations </plain></SENT>
</text></document>